Results 181 to 190 of about 2,286,378 (300)

High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. [PDF]

Molecules
Gerges A, Canning U.
europepmc   +1 more source

Activation of a Trk receptor is mediated by a disordered extracellular juxtamembrane region

, 2022
Sergey A. Goncharuk
openalex   +1 more source

Multi-Cancer Genome Profiling for Neurotrophic Tropomyosin Receptor Kinase (NTRK) Fusion Genes: Analysis of Profiling Database of 88,688 Tumors. [PDF]

Cancers (Basel)
Nishikubo H, Kawabata K, Kanei S, Aoyama R, Ma D, Sano T, Imanishi D, Sakuma T, Maruo K, Fan C, Yamamoto Y, Yashiro M.   +11 more
europepmc   +1 more source

Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling

, 2010
Christian B. Vægter, Pernille Jansen, Anja W. Fjorback, Simon Glerup, Sune Skeldal, Mads Kjølby, Mette Richner, Bettina Erdmann, Jens Randel Nyengaard, Lino Tessarollo, Gary R. Lewin, Thomas E. Willnow, Moses V. Chao, Anders Nykjær   +13 more
openalex   +2 more sources

CEP‐751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti‐tumor activity

International Journal of Cancer, 1997
A. M. Camoratto, J. Jani, T. Angeles, A. Maroney, Christa Sanders, C. Murakata, N. Neff, J. L. Vaught, J. Isaacs, C. Dionne   +9 more
semanticscholar   +1 more source

ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models

Cell Reports
Summary: Pediatric-type high-grade gliomas frequently harbor gene fusions involving receptor tyrosine kinase genes, including neurotrophic tyrosine kinase receptor (NTRK) fusions.
Sebastian Schmid, Zachary R. Russell, Alex Shimura Yamashita, Madeline E. West, Abigail G. Parrish, Julia Walker, Dmytro Rudoy, James Z. Yan, David C. Quist, Betemariyam N. Gessesse, Neriah Alvinez, Kimberly D. Hill, Larry W. Anderson, Patrick J. Cimino, Debra K. Kumasaka, Ralph E. Parchment, Eric C. Holland, Frank Szulzewsky   +17 more
doaj  

Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer. [PDF]

JCO Precis Oncol
Brose MS, Westphalen CB, Pan X, Bernard-Gauthier V, Kurtinecz M, Guo H, Aris V, Brett NR, Majdi A, Subbiah V, Pennell NA, Kehl KL, Drilon A.   +12 more
europepmc   +1 more source

Faculty Opinions recommendation of Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling.

, 2010
Louis F. Reichardt
openalex   +1 more source

Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated review. [PDF]

Jpn J Clin Oncol
Kubota Y, Kawano M, Iwasaki T, Itonaga I, Kaku N, Ozaki T, Tanaka K.   +6 more
europepmc   +1 more source

Practical pathological methods for reliable diagnosis of secretory carcinomas of the salivary gland. [PDF]

Discov Oncol
Kawaura R, Ishikawa T, Shibata H, Kuroki M, Kobayashi K, Hanamatsu Y, Miyazaki T, Tomita H, Ishihara T, Usubuchi H, Aoyama Y, Asada Y, Imai T, Ohkoshi A, Hara A, Katori Y, Furukawa T, Ogawa T.   +17 more
europepmc   +1 more source